Camphor Oil (Oleum Camphoratum): A Comprehensive Reference
1. Identity: Botanical Source, Chemical Name, and Common Forms
1.1 Botanical Source and Taxonomy
The camphor tree, Cinnamomum camphora (Linn.) J. Presl, belongs to the family Lauraceae. The tree is native to East Asia, particularly China, Japan, and Taiwan, but has been cultivated in various regions worldwide. A secondary natural source of related compounds exists: camphor formed in the stems of Dryobalanops aromatica Gaertn. (family Dipterocarpaceae) is natural borneol, a structurally related monoterpene. Camphor oil is obtained from the wood of the camphor cinnamon tree that grows in Japan, China, Vietnam, Asia, Africa, Sri Lanka, Australia, Canada, and the United States.
1.2 Chemical Identity
Camphor (C₁₀H₁₆O) is a white crystalline solid with enantiomeric forms: R-camphor and S-camphor. Chemically, camphor is a terpenoid ketone obtained from the camphor tree (Cinnamomum camphora). It is a waxy, flammable solid with a strong odor, and structurally it is made up of a bicyclic monoterpene skeleton. The aroma of both the racemic mixture and the laevo enantiomer are described as "camphoreous," whereas the dextro enantiomer exhibits a more complex aroma described as camphoreous, minty, phenolic, herbal, woody, medicinal, mentholic, cooling, and green.
1.3 Extraction and Preparation
Camphor is primarily obtained through steam distillation of the wood but can also be synthetically produced from turpentine. The Ayurvedic Pharmacopoeia of India records natural camphor obtained during steam distillation of the leaves and barks of Cinnamomum camphora as the correct variety to be used in different Ayurvedic formulations.
The term "camphor oil" encompasses several distinct preparations derived from the distillation process:
- White camphor oil: Camphor white oil (CWO) is produced by steam distillation of wood from the camphor laurel tree (Cinnamomum camphora). CWO primarily consists of a mixture of structurally related terpenes, a class of chemical compounds composed of isoprene units that plants generate for defensive purposes. Abundant constituents of CWO include eucalyptol, a natural cough suppressant, and limonene, an antiseptic. Counterintuitively, camphor is found at only trace amounts in this distillate.
- Camphorated oil (traditional): Camphor liniment was a 20% w/w camphor formulation in either cottonseed oil or arachis oil.
- Essential oil of C. camphora: Essential oil from the leaves of C. camphora can be isolated using the hydrodistillation method and analyzed for its chemical composition.
- Topical OTC preparations: Medicinally, camphor is employed externally as a rubefacient, a mild analgesic, an antipruritic, and a counterirritant in commercially available products that contain 1–10% camphor.
- Solid camphor: In its solid form, camphor is a white powder with a very intense odor that easily converts to a gas. The most commonly used form is camphor oil (Oleum camphoratum).
2. Traditional and Historical Use
2.1 Ancient and Medieval World
Camphor had strong global appeal well before the 19th century. Even Marco Polo, who mentioned it in his 13th-century travel logs, was late to the game. Sixth-century traditional Chinese medicine practitioners were already using top-quality medicinal camphor; Hindus were using camphor in ceremonies to represent the eternal flame of Lord Shiva; and Muslim scholars claim camphor is one of the handful of plants mentioned in the Quran.
One of the earliest known recipes for ice cream, dating to the Tang dynasty, includes camphor as an ingredient. It was used to flavor leavened bread in ancient Egypt. In ancient and medieval Europe, camphor was used as an ingredient in sweets.
The Chinese referred to the best camphor as "dragon's brain perfume," due to its "pungent and portentous aroma" and centuries of uncertainty over its provenance and mode of origin.
Camphor was one of the therapeutic agents of the 19th-century pharmacopoeia used as an analgesic, expectorant, counterirritant, and abortifacient, as well as a stimulant. It has been claimed that camphor was mentioned by Marco Polo in the 13th century and by Camoens in 1571, who called it the "balsam of disease." Camphor was highly prized by the Chinese, who used it for embalming purposes and to scent soap.
Camphor was used as a fumigation agent during the outbreak of smallpox and the Black Death; the body was covered with rose water and camphor perfume when the body was buried.
2.2 Traditional Chinese Medicine (TCM)
Camphor was used for centuries in traditional Chinese medicine for various purposes. Cinnamomum camphora (Linn.) Presl has been widely used in traditional Chinese medicine for a variety of purposes. In TCM, borneol — a closely related constituent — is regarded as a "guide drug" that facilitates the delivery of other medicinal compounds to target tissues, particularly the brain, due to its ability to cross the blood–brain barrier. Essential oils from C. camphora have long been prescribed in traditional medicine for the treatment of inflammation-related diseases, such as rheumatism, bronchitis, and muscle pains.
2.3 Ayurveda and South Asian Traditions
In Ayurveda, camphor is popularly known as Karpura and used to treat bronchitis, fever, chest congestion, diarrhea, dysentery, eye diseases, heart problems, and gynecological disorders. In Ayurveda, C. camphora was also used to treat colds, edema, and flu, and in Greece it was used as a head tonic and heart treatment. Internally, camphor is used in Ayurveda — the ancient East Indian system of healing — and Traditional Chinese Medicine to strengthen and activate the nervous system and stimulate digestion.
A variety of uses of camphor were mentioned in the Ayurveda and followed from ancient times. In homeopathy, camphor was also used in small doses to treat various conditions, with its use in the form of a tincture called the "divine remedy."
2.4 Other Regional Traditions
Camphor was used in ancient Sumatra to treat sprains, swellings, and inflammation. Historically, camphor was widely used in Asia and the Middle East, often in incense, as an embalming agent, and for medicinal purposes like treating inflammation, pain, and respiratory issues.
This substance has been used for centuries as an antipruritic, topical vasodilator, inducer of miscarriage, aphrodisiac, contraceptive, anti-common-cold drug, moth repellent, inhibitor of lactation, and antiseptic.
Camphor is also used as a repellent for certain insects, in particular moths, and it has been used historically as an ingredient in foods and beverages, particularly in liquors and sweet dishes. Camphor is still used as a flavoring for certain foods in India and other parts of Asia.
2.5 19th-Century and Early Modern Medical Use
Camphor was one of the therapeutic agents of the 19th-century pharmacopoeia used as an analgesic, expectorant, counterirritant, and abortifacient, as well as a stimulant. Following a large number of accidental poisonings, the Food and Drug Administration ruled in 1983 that camphorated oil could no longer be sold over-the-counter (OTC).
3. Key Constituents and Chemical Composition
3.1 Primary Active Compound: Camphor
Camphor itself — a bicyclic monoterpene ketone — is the dominant and most studied constituent. Its relative proportion varies substantially depending on the plant part used, the geographic origin, and extraction method. The leaf oil of C. camphora from Makwanpur, Nepal, was dominated by camphor (36.5%), camphene (11.7%), and limonene (9.0%), whereas the leaf oil from Kavre, Nepal, contained almost exclusively camphor (98.0%). In the Doon Valley region of India, the essential oil was dominated by monoterpenes amounting to 88.06%, with D-camphor (46.06%), limonene (9.74%), α-pinene (9.71%), β-myrcene (4.91%), and camphene (4.37%) as major constituents.
3.2 Full Chemical Profile by Plant Part
The composition and content ratio of essential oil from C. camphora differ depending on the plant part.
- Leaf oil: The predominant compound in the leaf oil is camphor (93.1%), followed by camphene (1.8%) and α-pinene (1.6%).
- Bark (stem) oil: The main components of the bark essential oil are D-camphor (51.3%), 1,8-cineole (4.3%), α-terpineol (3.8%), and 3-methyl-2-butenoic acid, oct-3-en-2-yl ester (3.1%).
- Fruit oil: Safrole (29.0%), D-camphor (28.1%), linalool (12.8%), and 1,8-cineole (5.3%) are the main constituents of the fruit essential oil.
- Seed oil: The major components are eucalyptol (20.90%), methyleugenol (19.98%), linalool (14.66%), and camphor (5.5%).
- Twig oil: The main compounds in the twig oil are eucalyptol (17.21%), camphor (13.17%), and 3,7-dimethyl-1,3,7-octatriene (11.47%).
Other significant chemical constituents of C. camphora include linalool, camphene, dipentene, borneol, and safrole. The essential oil of Cinnamomum camphora contains approximately 330 different compounds, including linalool and camphor, which are the main antibacterial components.
3.3 Environmental Influence on Composition
The biosynthesis of secondary metabolites and the proportion of individual substances in essential oils vary due to environmental factors, such as seasonal variation, geographic changes, light availability, vegetation and microorganisms, and soil pH.
4. Mechanisms of Action
4.1 TRP Channel Interactions: Analgesia and Sensory Modulation
The molecular pharmacology of camphor has been substantially elucidated through ion-channel research. Capsaicin and menthol, two other topically applied agents widely used for similar purposes, are known to excite and desensitize sensory nerves by acting on two members of the transient receptor potential (TRP) channel superfamily: heat-sensitive TRP vanilloid subtype 1 (TRPV1) and cold-sensitive TRP channel M8 (TRPM8), respectively. Camphor has been shown to activate TRPV3, and it also activates heterologously expressed TRPV1, requiring higher concentrations than capsaicin.
Activation of TRPV1 by camphor is enhanced by phospholipase C-coupled receptor stimulation, mimicking inflamed conditions.
Camphor inhibits TRPA1 and activates TRPM8. The activation of TRPM8 by camphor contributes to its analgesic effects, while inhibition of TRPA1 reduces nociception. Camphor's ability to modulate both TRPM8 and TRPA1 makes it a valuable compound for pain management.
Camphor and menthol belong to a class of analgesics known as counterirritants. Counterirritants exert their effects by first activating and then desensitizing nociceptors in the skin. Pharmacologically, camphor acts as a counterirritant, producing a cooling effect followed by warmth, which helps relieve pain by stimulating nerve endings.
4.2 Anti-Inflammatory Mechanisms
Ethanol extract of C. camphora has been reported to block the production of interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) from RAW264.7 cells stimulated by lipopolysaccharide. The essential oil from C. camphora leaves significantly decreased the release of nitric oxide (NO) and the mRNA expression of inducible NO synthase (iNOS) in lipopolysaccharide (LPS)-induced BV2 microglial cells.
Camphor regulates Toll-like receptors (TLRs) 4 and nuclear factor erythroid 2-related factor 2 (Nrf-2) to decrease the secretion of pro-inflammatory cytokines and enhance antioxidant activity, thereby reducing inflammation.
4.3 Antitussive Mechanism
Camphorated oil contains camphor, which initially stimulates but then strongly desensitizes TRPV1, providing a mechanistic basis for its antitussive (cough-suppressing) action. The TRPV1 channel has been proposed as a common final pathway underlying the heightened cough sensitivity of individuals with unexplained chronic cough (UCC). The presence of TRPV1 in vagal afferents and the lower threshold to capsaicin-induced cough in patients with UCC have suggested a central role for TRPV1 hyperexpression and hyperfunction in chronic cough.
4.4 Antimicrobial Mechanisms
Mechanistic studies have revealed that essential oil from C. camphora disrupts the bacterial cell wall, causing leakage of nucleic acids and proteins, and ultimately bacterial death. A combination of 1,8-cineole and camphor has been shown to produce a synergistic interaction and improve the antimicrobial effect on Candida albicans.
5. Scientific Evidence by Area of Use
5.1 Topical Analgesia and Pain Relief
Although placebo-controlled studies utilize camphor in combination with other key ingredients, the mechanisms of action for camphor's analgesic and anesthetic effects have been well-validated. Camphor functions as a counterirritant that initially activates and then desensitizes pain receptors.
A notable human clinical study examined a combination containing camphor for osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee was published in the Journal of Rheumatology in 2003.
Ingredients like camphor, menthol, and salicylates provide a distraction from pain through a cooling or warming sensation. However, these are characterized as providing sensory distraction rather than targeted anti-inflammatory action comparable to NSAIDs. Most placebo-controlled clinical studies have examined camphor only in combination preparations, making it difficult to isolate the independent analgesic contribution of camphor alone.
In preclinical (animal) models, camphor essential oil (EOOK) was tested in a carrageenan-induced paw edema model with oral doses of 30, 100, and 300 mg/kg, and in a zymosan-induced articular inflammation model, with camphor isolated at 30 mg/kg orally. This study demonstrated that camphor and some known anti-inflammatory compounds present in EOOK could contribute to analgesic and anti-inflammatory articular properties. These findings are preclinical only and do not directly translate to human dosing conclusions.
Evidence strength: The mechanistic basis for camphor as a topical counterirritant/analgesic is well-established at the molecular level. Human clinical evidence is limited and largely derived from combination product trials, not camphor monotherapy.
5.2 Antitussive (Cough Suppression)
The FDA classified camphor as Category I for topical (ointment) or steam inhalant antitussive use, but camphor as a single ingredient is limited to ointment and steam inhalation use. The FDA recognized camphor as a safe and effective topical antitussive, analgesic, anesthetic, and antipruritic agent, and set a product limit of 11% camphor concentration.
The OTC monograph included the ingredients camphor and menthol as single topical antitussives in an ointment vehicle or for steam inhalation use. Camphorated oil, which contains camphor, initially stimulates but then strongly desensitizes TRPV1, providing a plausible mechanism. Clinical evidence for the antitussive action of camphor has been reported in published commentary.
Despite the public health burden of the common cold, there are no clinically proven, FDA-approved drugs or other remedies with robust evidence to effectively lower symptom severity or shorten illness duration. OTC camphor-containing preparations for cough reflect historical regulatory classification more than modern placebo-controlled human clinical trial evidence specifically for camphor.
Evidence strength: Regulatory (FDA Category I) recognition as an OTC topical antitussive is established. Mechanistic evidence via TRPV1 desensitization is strong. Independent clinical trial evidence for camphor's antitussive efficacy in humans (isolated from combination products) remains limited.
5.3 Antimicrobial Activity
The essential oil of Cinnamomum camphora has a broad range of antimicrobial, insecticidal, anti-inflammatory, and antioxidant activities. It contains approximately 330 different compounds, including linalool and camphor, which are the main antibacterial components. Many studies have been carried out on the antibacterial activity of CCEO, revealing activities against Escherichia coli, Staphylococcus aureus, and Choanephora cucurbitarum.
The minimum inhibitory concentration (MIC) for 90% of organisms was reported at 4.297 μL/mL, and the minimum bactericidal concentration for 90% of organisms was 6.378 μL/mL.
Regarding antibiofilm activity, one camphoryl pyrimidine amine derivative showed activity against P. aeruginosa, E. coli, and MRSA S. aureus, with MIC values of 16, 8, and 8 μg/mL, respectively.
Regarding antifungal activity, a study comparing borneol-type essential oil from C. camphora (BEO) against Staphylococcus epidermidis found that minimum inhibitory concentrations, determined by broth microdilution, were identical for both BEO and natural crystalline borneol (0.5 mg/mL). Despite this, BEO exhibited stronger antibacterial activity, suggesting synergistic enhancement by other components.
Evidence strength: Antimicrobial activity is well-documented in in vitro studies across multiple bacterial and fungal species. Human clinical trial evidence for treating infections with camphor oil in people is essentially absent. Findings are currently preclinical.
5.4 Anti-Inflammatory Activity
In LPS-induced RAW 264.7 macrophages, borneol-rich essential oil from C. camphora dose-dependently reduced the production of TNF-α, IL-1β, and IL-6. Compared to limonene and 1,8-cineole, camphor molecules interact with more therapeutic targets associated with inflammation.
These are uniformly in vitro and animal-model findings. There are no robust placebo-controlled human clinical trials specifically testing camphor oil's anti-inflammatory effects as a primary endpoint in human inflammatory conditions. Evidence strength: Preclinical only.
5.5 Anticancer / Antitumor Activity
Bioactive derivatives from the camphor laurel tree are posited to exhibit chemopreventive properties, but the efficacy and mechanism of these natural products are not fully understood. In a mouse model of keratinocyte-derived skin cancer, daily topical treatment with camphor white oil (CWO) induced dramatic regression of pre-malignant skin tumors and a two-fold reduction in cutaneous squamous cell carcinomas. In cultured keratinocytes, CWO stimulated calcium signaling, resulting in calcineurin-dependent activation of nuclear factor of activated T cells (NFAT). In vivo, CWO induced transcriptional changes in immune-related genes identified by RNA-sequencing, resulting in cytotoxic T cell-dependent tumor regression.
Studies have shown that some of the components of Cinnamomum camphora have suppressive and anti-mutagenic effects in a number of human cancer cells without harming the healthy cells. However, in recent years, essential oils have garnered heightened interest for their therapeutic value in treating human ailments; however, the efficacy of such treatments and their mechanisms of action have rarely been tested in controlled studies.
Evidence strength: Animal model and in vitro evidence only. No human clinical trials examining camphor oil as a cancer treatment or preventive have been reported in the peer-reviewed literature. These findings are preliminary and exploratory.
5.6 Insecticidal and Repellent Activity
The essential oils of Cinnamomum camphora have been found to possess strong fumigant toxicity against Tribolium castaneum and Lasioderma serricorne adults. The stem bark and leaf essential oils exhibited strong fumigant toxicity against the red flour beetle and cigarette beetle, with LC₅₀ values both less than 3.2 mg/L air. These findings are derived from controlled laboratory insecticidal assays rather than human clinical trials.
5.7 Skin and Dermatological Applications
One study suggested essential oil of C. camphora as a natural treatment for skin inflammation and the possibility of applying medicinal plants to treat various inflammation-related diseases. Extracts from C. camphora exhibit a wide range of biological properties, including antimicrobial, anti-inflammatory, analgesic, and neuroprotective effects.
Evidence strength: Limited to in vitro and case-series-level evidence for dermatological applications. No large randomized controlled trials specifically for camphor oil in skin conditions have been identified.
6. Body Systems and Health Areas Associated with Camphor Oil
- Musculoskeletal system: Camphor obtained from camphor trees has long been used as a treatment for various symptoms such as inflammation, infection, congestion, muscle pain, and irritation.
- Respiratory system: When inhaled, camphor acts as a decongestant, and its vapor can open up airways, providing relief from nasal and respiratory blockages.
- Nervous system / pain pathways: Camphor acts on TRPV1, TRPV3, TRPM8, and TRPA1 channels expressed in nociceptive sensory neurons, modulating pain and temperature sensation.
- Immune/inflammatory system: In preclinical models, camphor suppresses pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and nitric oxide production.
- Integumentary system (skin): Used topically as an antipruritic, rubefacient, and counterirritant.
- Cardiovascular system: Camphor is sometimes used topically to treat cardiac symptoms, a use that traces back to historical practices in which it was used as a circulatory stimulant, though this use is not supported by modern clinical evidence.
7. Dosage Forms and Reported Dosages
The following dosages are reported directly from cited sources and should not be construed as prescriptive recommendations:
- Topical OTC products (FDA-sanctioned range): Commercially available topical products contain 1–10% camphor. The FDA set a product limit of 11% camphor concentration for topical preparations.
- Topical cream for pain: A topical cream containing camphor is applied to the affected area up to 4 times per day for up to 2 weeks.
- Inhalation (antitussive): For cough, camphor-containing products are inhaled via vaporizer up to 3 times per day.
- OTC labeled concentration (common product example): One NLM-listed OTC preparation contains organic camphor at 5.0% as its topical antitussive active ingredient.
- Preclinical animal doses (not human doses): In rodent models, essential oil was tested in a carrageenan-induced paw edema model with oral doses of 30, 100, and 300 mg/kg, and in a zymosan-induced articular inflammation model at 100 mg/kg. These are animal research doses only.
- Toxic internal dose threshold: In children, ingestion of a total dose of 500–1,000 mg and a dose above 30 mg/kg is defined as toxic and high-dose camphor ingestion. Internal doses over 2 grams have caused convulsions, delirium, hallucinations, and death.
8. Safety Considerations and Interactions
8.1 Regulatory Status and Banned Preparations
The FDA recognized camphor as a safe and effective topical antitussive, analgesic, anesthetic, and antipruritic agent, and set a product limit of 11% camphor concentration. The FDA completely banned products labeled as camphorated oil, camphor oil, camphor liniment, and camphorated liniment. Following a large number of accidental poisonings, the FDA ruled in 1983 that camphorated oil could no longer be sold over-the-counter.
8.2 Absorption and Systemic Toxicity
Camphor is a neurotoxic compound that can be easily absorbed through mucosa, the gastrointestinal system, skin, and respiratory system because of its lipophilic properties. Depending on the dose ingested, initial gastrointestinal findings include nausea and vomiting, followed by central nervous system effects including hyperactivity, tremor, headache, hallucinations, dizziness, delirium, clouded consciousness, seizure, apnea, respiratory arrest, and coma. In addition, elevated transaminase levels, hepatic damage, hepatosteatosis, urinary retention, albuminuria, and sinus tachycardia may be observed.
8.3 Neurotoxicity and Seizure Risk
Camphor is a highly toxic ingredient that can be found in commonly used rubs and preparations such as Tiger Balm and Vicks. There is a wide range of symptoms resulting from camphor oil toxicity, manifesting in sweating and agitation, and progressing to more serious symptoms of seizures, cardiac arrhythmias, and cardiopulmonary arrest.
Approximately 3–5 mL of 20% camphor oil or >30 mg/kg is considered a potentially lethal dose. Death occurs as a result of respiratory arrest and unstoppable seizures.
8.4 Pediatric Vulnerability
Camphor is a highly toxic compound that, even in very small concentrations, can be lethal to infants and children. The strong aroma associated with camphor has attracted its use in many oils, inhalants, and ointments, especially as a remedy for the common cold, which increases the risk of accidental pediatric exposure. No consensus guidelines exist for toxic serum levels in the pediatric population.
8.5 Cardiac Effects
ECG findings associated with camphor oil toxicity include borderline QT prolongation and widening of the QRS complex. Case reports have documented cardiac arrhythmias following ingestion, in addition to seizures and respiratory compromise.
8.6 Hepatotoxicity
As noted above, elevated transaminase levels, hepatic damage, and hepatosteatosis may be observed with significant camphor exposure.
8.7 Flammability
Use of topical/inhalant products containing camphor near a flame, in hot water, or in a microwave oven may cause the products to splatter and cause serious burns. The FDA has added flammability warnings to OTC antitussive drug products containing camphor.
8.8 Presence of Safrole
Some chemotypes of C. camphora oil, particularly fruit oil, contain substantial quantities of safrole. Safrole (29.0%), D-camphor (28.1%), linalool (12.8%), and 1,8-cineole (5.3%) are the main constituents of the fruit essential oil. Safrole is classified as a carcinogenic compound and its presence in camphor-derived oils is a recognized regulatory concern, particularly for orally consumed or high-concentration preparations.
8.9 Traditional Internal Use Risks
Internally, camphor is used in Ayurveda and Traditional Chinese Medicine to strengthen and activate the nervous system and stimulate digestion. However, internal doses over 2 grams have caused convulsions, delirium, hallucinations, and death.
8.10 Drug and Interaction Profile
Camphor is readily absorbed through skin, mucous membranes, and the gastrointestinal tract. Given its CNS-stimulant effects at elevated exposures, camphor may theoretically interact with other CNS-active agents, but specific pharmacokinetic drug–drug interaction studies in humans are not available in the published literature. Inhalation products containing camphor should be used with caution in patients with chronic or persistent cough such as from smoking or lung diseases.
References
Go back